Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06458530 · ClinicalTrials.gov registry record · NA
Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.
A NA study of PreDiabetes and Muscle Weakness, sponsored by Impactiv.
- Active
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT06458530: Active NA study of PreDiabetes and Muscle Weakness, sponsored by Impactiv.
NCT06458530 is a NA study of PreDiabetes and Muscle Weakness that is active but no longer recruiting, run by Impactiv. The registered enrollment target is 74 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06458530, a NA study of PreDiabetes and Muscle Weakness, is active but no longer recruiting, sponsored by Impactiv.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control.
Primary Outcome
Lower body strength measured by the 30-second chair stand
Conditions Studied
Interventions
- BEHAVIORAL Vivo
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2024-07-09 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT06458530 still lists
NCT06458530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Vivo is the first listed.
NCT06458530 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06458530 about?
NCT06458530 is a clinical study titled "Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.". This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control.
What is the current status of trial NCT06458530?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2024-07-09. Estimated completion is 2026-03-31.
What conditions does trial NCT06458530 study?
This clinical trial studies the following conditions: PreDiabetes, Muscle Weakness, Muscle Loss, Older Adult.
What interventions are being tested in trial NCT06458530?
The interventions under investigation include: Vivo (BEHAVIORAL).
Who is sponsoring clinical trial NCT06458530?
This trial is sponsored by Impactiv, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06458530 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06458530's enrollment target sits among peer trials
74 77th of 149 higher than 73 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI